ロード中...
iRECIST: how to do it
BACKGROUND: iRECIST for the objective monitoring of immunotherapies was published by the official RECIST working group in 2017. MAIN BODY: Immune-checkpoint inhibitors represent one of the most important therapy advancements in modern oncology. They are currently used for treatment of multiple malig...
保存先:
| 出版年: | Cancer Imaging |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6942293/ https://ncbi.nlm.nih.gov/pubmed/31900236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-019-0281-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|